EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $85,843 | -56.5% | 25,248 | -6.0% | 0.00% | 0.0% |
Q2 2023 | $197,318 | -29.8% | 26,846 | -1.0% | 0.00% | -50.0% |
Q1 2023 | $280,901 | -11.7% | 27,114 | +0.6% | 0.00% | 0.0% |
Q4 2022 | $318,256 | -44.2% | 26,948 | -0.7% | 0.00% | -50.0% |
Q3 2022 | $570,000 | -31.7% | 27,147 | +1.0% | 0.00% | -33.3% |
Q2 2022 | $834,000 | -27.4% | 26,867 | -4.0% | 0.01% | 0.0% |
Q1 2022 | $1,149,000 | -11.0% | 27,983 | -5.8% | 0.01% | 0.0% |
Q4 2021 | $1,291,000 | -76.3% | 29,704 | -72.6% | 0.01% | -79.3% |
Q3 2021 | $5,437,000 | -19.9% | 108,595 | +0.7% | 0.03% | +26.1% |
Q2 2021 | $6,790,000 | -34.0% | 107,795 | -2.6% | 0.02% | -36.1% |
Q1 2021 | $10,283,000 | +4.2% | 110,674 | +0.5% | 0.04% | -2.7% |
Q4 2020 | $9,867,000 | -12.0% | 110,121 | +1.4% | 0.04% | -31.5% |
Q3 2020 | $11,218,000 | +349.4% | 108,565 | +243.9% | 0.05% | +350.0% |
Q2 2020 | $2,496,000 | +38.2% | 31,568 | +1.1% | 0.01% | +20.0% |
Q1 2020 | $1,806,000 | +2.1% | 31,218 | -4.8% | 0.01% | +42.9% |
Q4 2019 | $1,768,000 | +0.6% | 32,778 | -2.6% | 0.01% | 0.0% |
Q3 2019 | $1,758,000 | +6.5% | 33,636 | -1.5% | 0.01% | +16.7% |
Q2 2019 | $1,650,000 | -4.8% | 34,164 | -0.5% | 0.01% | -14.3% |
Q1 2019 | $1,734,000 | -17.0% | 34,319 | -2.6% | 0.01% | -22.2% |
Q4 2018 | $2,088,000 | -9.1% | 35,227 | +1.0% | 0.01% | +12.5% |
Q3 2018 | $2,296,000 | +37.0% | 34,877 | +5.1% | 0.01% | +33.3% |
Q2 2018 | $1,676,000 | +48.6% | 33,192 | +55.0% | 0.01% | +50.0% |
Q1 2018 | $1,128,000 | -9.5% | 21,419 | -20.2% | 0.00% | 0.0% |
Q4 2017 | $1,247,000 | +15.4% | 26,843 | +0.5% | 0.00% | 0.0% |
Q3 2017 | $1,081,000 | +26.3% | 26,717 | +5.8% | 0.00% | +33.3% |
Q2 2017 | $856,000 | +47.3% | 25,257 | +26.2% | 0.00% | +50.0% |
Q1 2017 | $581,000 | -26.6% | 20,006 | -17.0% | 0.00% | -33.3% |
Q4 2016 | $792,000 | -99.9% | 24,110 | -1.5% | 0.00% | 0.0% |
Q3 2016 | $771,602,000 | +14.5% | 24,472 | +2.1% | 0.00% | 0.0% |
Q2 2016 | $673,840,000 | -19.5% | 23,963 | +4.1% | 0.00% | 0.0% |
Q1 2016 | $837,000,000 | -5.4% | 23,012 | +4.0% | 0.00% | -25.0% |
Q4 2015 | $885,000,000 | +141726.9% | 22,120 | +1.1% | 0.00% | +33.3% |
Q3 2015 | $624,000 | -99.9% | 21,870 | +0.8% | 0.00% | 0.0% |
Q2 2015 | $714,950,000 | +13.0% | 21,698 | -1.4% | 0.00% | 0.0% |
Q1 2015 | $632,950,000 | +6.7% | 22,008 | +1.0% | 0.00% | 0.0% |
Q4 2014 | $593,178,000 | +24.1% | 21,784 | -2.9% | 0.00% | +50.0% |
Q3 2014 | $478,047,000 | -4.7% | 22,433 | +0.4% | 0.00% | 0.0% |
Q2 2014 | $501,869,000 | -8.0% | 22,345 | +3.5% | 0.00% | -33.3% |
Q1 2014 | $545,706,000 | +13.1% | 21,595 | +2.9% | 0.00% | +50.0% |
Q4 2013 | $482,376,000 | +21.5% | 20,982 | +0.6% | 0.00% | 0.0% |
Q3 2013 | $397,135,000 | +36.2% | 20,847 | +3.1% | 0.00% | 0.0% |
Q2 2013 | $291,688,000 | – | 20,228 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |